Ryu Sasaki

19PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersExercise physiologyBehavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 05, 2026
Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab.

|Sep 08, 2026
The Five-Time Chair Stand Test Identifies Patients With Liver Cirrhosis at High Mortality Risk Overlooked by Conventional Sarcopenia Criteria.

|Aug 26, 2026
Intracellular Water Indexed to Height Squared as a Complementary Marker to Skeletal Muscle Index Across Nutritional and Hydration Status.

|Jun 12, 2026
Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study.

|Dec 19, 2025
Plasma Vascular Endothelial Growth Factor-A Identified by Proximity Extension Assay Predicts Early Progression in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab.

Kazuaki Tajima, Satoshi Miuma, Ryu Sasaki

|Nov 28, 2025
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B.

Ryu Sasaki, Shigeo Shimose, Issei Saeki

Pageof 4

Frequent Collaborators

11 joint publications

Hisamitsu Miyaaki

6 joint publications

Satoshi Miuma

6 joint publications

Shigeo Shimose

5 joint publications

Takumi Kawaguchi